Second Sight Medical Products (EYES) Stock
EYES is no longer traded. Second Sight Medical Products was delisted from the Nasdaq in August 2022.
Prices on this page are historical; the last trade was August 30, 2022 at $4.14.
Second Sight Medical Products stock price history
EYES final trading statistics
- Final close
- $4.14
- Final trading day
- Aug 30, 2022
- Market cap at delisting
- $54.38M
- Shares outstanding
- 13.14M
- Final 52-week range
- $1.14 – $5.50
- Avg. volume (final 3 mo.)
- 232,562
- All-time high (split-adj.)
- $10045.44 · Mar 2015
- All-time low (split-adj.)
- $2.19 · Sep 2020
- Return since IPO
- -99.1%
- Beta
- 2.56
- Book value / share
- $4.80
- Price / book
- 0.86
Second Sight Medical Products annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $260.00 | -$8.9K | -$0.43 |
| FY2020 | $1.0K | -$14.9M | -$2.49 |
| FY2019 | $3.38M | -$33.6M | -$7.02 |
| FY2018 | $6.90M | -$35.1M | -$4.24 |
| FY2017 | $7.96M | -$28.5M | -$2.28 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Second Sight Medical Products
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
Second Sight Medical Products stock FAQ
What happened to Second Sight Medical Products stock?
Second Sight Medical Products stock was delisted from the Nasdaq. Its final close was $4.14 on August 30, 2022.
Is EYES stock still trading?
No. EYES was delisted from the Nasdaq in August 2022 and no longer trades on a U.S. exchange.
What was the last price of EYES stock?
EYES closed at $4.14 on its final trading day, August 30, 2022, for a market value of about $54.38M.
What were Second Sight Medical Products's revenue and earnings in its last full fiscal year?
Second Sight Medical Products reported revenue of $260.00 and net income of -$8.9K in fiscal 2021, its last full year as a public company.
When did Second Sight Medical Products go public?
Second Sight Medical Products stock began trading on November 19, 2014.